These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 19944073)
1. Mitochondria sense with different kinetics the calcium entering into HeLa cells through calcium channels CALHM1 and mutated P86L-CALHM1. Moreno-Ortega AJ; Ruiz-Nuño A; García AG; Cano-Abad MF Biochem Biophys Res Commun; 2010 Jan; 391(1):722-6. PubMed ID: 19944073 [TBL] [Abstract][Full Text] [Related]
2. CALHM1 and its polymorphism P86L differentially control Ca²⁺homeostasis, mitogen-activated protein kinase signaling, and cell vulnerability upon exposure to amyloid β. Moreno-Ortega AJ; Buendia I; Mouhid L; Egea J; Lucea S; Ruiz-Nuño A; López MG; Cano-Abad MF Aging Cell; 2015 Dec; 14(6):1094-102. PubMed ID: 26416646 [TBL] [Abstract][Full Text] [Related]
3. Calcium homoeostasis modulator 1 (CALHM1) reduces the calcium content of the endoplasmic reticulum (ER) and triggers ER stress. Gallego-Sandín S; Alonso MT; García-Sancho J Biochem J; 2011 Aug; 437(3):469-75. PubMed ID: 21574960 [TBL] [Abstract][Full Text] [Related]
4. Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease. Nacmias B; Tedde A; Bagnoli S; Lucenteforte E; Cellini E; Piaceri I; Guarnieri BM; Bessi V; Bracco L; Sorbi S J Alzheimers Dis; 2010; 20(1):37-41. PubMed ID: 20164602 [TBL] [Abstract][Full Text] [Related]
5. CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model. Boada M; Antúnez C; López-Arrieta J; Galán JJ; Morón FJ; Hernández I; Marín J; Martínez-Lage P; Alegret M; Carrasco JM; Moreno C; Real LM; González-Pérez A; Tárraga L; Ruiz A J Alzheimers Dis; 2010; 20(1):247-51. PubMed ID: 20164592 [TBL] [Abstract][Full Text] [Related]
6. Rare variants in calcium homeostasis modulator 1 (CALHM1) found in early onset Alzheimer's disease patients alter calcium homeostasis. Rubio-Moscardo F; Setó-Salvia N; Pera M; Bosch-Morató M; Plata C; Belbin O; Gené G; Dols-Icardo O; Ingelsson M; Helisalmi S; Soininen H; Hiltunen M; Giedraitis V; Lannfelt L; Frank A; Bullido MJ; Combarros O; Sánchez-Juan P; Boada M; Tárraga L; Pastor P; Pérez-Tur J; Baquero M; Molinuevo JL; Sánchez-Valle R; Fuentes-Prior P; Fortea J; Blesa R; Muñoz FJ; Lleó A; Valverde MA; Clarimón J PLoS One; 2013; 8(9):e74203. PubMed ID: 24069280 [TBL] [Abstract][Full Text] [Related]
7. CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease. Koppel J; Campagne F; Vingtdeux V; Dreses-Werringloer U; Ewers M; Rujescu D; Hampel H; Gordon ML; Christen E; Chapuis J; Greenwald BS; Davies P; Marambaud P Mol Med; 2011; 17(9-10):974-9. PubMed ID: 21629967 [TBL] [Abstract][Full Text] [Related]
9. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Ferreiro E; Resende R; Costa R; Oliveira CR; Pereira CM Neurobiol Dis; 2006 Sep; 23(3):669-78. PubMed ID: 16844381 [TBL] [Abstract][Full Text] [Related]
10. CALHM1 P86L polymorphism is a risk factor for Alzheimer's disease in the Chinese population. Cui PJ; Zheng L; Cao L; Wang Y; Deng YL; Wang G; Xu W; Tang HD; Ma JF; Zhang T; Ding JQ; Cheng Q; Chen SD J Alzheimers Dis; 2010; 19(1):31-5. PubMed ID: 20061624 [TBL] [Abstract][Full Text] [Related]
12. Sorting of calcium signals at the junctions of endoplasmic reticulum and mitochondria. Csordás G; Hajnóczky G Cell Calcium; 2001 Apr; 29(4):249-62. PubMed ID: 11243933 [TBL] [Abstract][Full Text] [Related]
13. Calcium homeostasis modulator 1 gene P86L polymorphism and the risk for alzheimer's disease: A meta-analysis. Mun MJ; Kim JH; Choi JY; Jang WC Neurosci Lett; 2016 Apr; 619():8-14. PubMed ID: 26944452 [TBL] [Abstract][Full Text] [Related]
14. Linking calcium to Abeta and Alzheimer's disease. Green KN; LaFerla FM Neuron; 2008 Jul; 59(2):190-4. PubMed ID: 18667147 [TBL] [Abstract][Full Text] [Related]
15. Mobilization of Ca2+ from endoplasmic reticulum to mitochondria plays a positive role in the early stage of UV- or TNFalpha-induced apoptosis. Lao Y; Chang DC Biochem Biophys Res Commun; 2008 Aug; 373(1):42-7. PubMed ID: 18544340 [TBL] [Abstract][Full Text] [Related]
16. CALHM1 P86L polymorphism does not alter amyloid-beta or tau in cerebrospinal fluid. Giedraitis V; Glaser A; Sarajärvi T; Brundin R; Gunnarsson MD; Schjeide BM; Tanzi RE; Helisalmi S; Pirttilä T; Kilander L; Lannfelt L; Soininen H; Bertram L; Ingelsson M; Hiltunen M Neurosci Lett; 2010 Jan; 469(2):265-7. PubMed ID: 20005921 [TBL] [Abstract][Full Text] [Related]
17. Benzothiazepine CGP37157 and its 2'-isopropyl analogue modulate Ca²⁺ entry through CALHM1. Moreno-Ortega AJ; Martínez-Sanz FJ; Lajarín-Cuesta R; de Los Rios C; Cano-Abad MF Neuropharmacology; 2015 Aug; 95():503-10. PubMed ID: 25908402 [TBL] [Abstract][Full Text] [Related]
18. No association between CALHM1 and risk for Alzheimer dementia in a Belgian population. Sleegers K; Brouwers N; Bettens K; Engelborghs S; van Miegroet H; De Deyn PP; Van Broeckhoven C Hum Mutat; 2009 Apr; 30(4):E570-4. PubMed ID: 19191332 [TBL] [Abstract][Full Text] [Related]
19. Combined modulation of the mitochondrial ATP-dependent potassium channel and the permeability transition pore causes prolongation of the biphasic calcium dynamics. Dahlem YA; Wolf G; Siemen D; Horn TF Cell Calcium; 2006 May; 39(5):387-400. PubMed ID: 16513166 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Ca2+ uptake with and without the formation of high-Ca2+ microdomains. Szanda G; Koncz P; Várnai P; Spät A Cell Calcium; 2006; 40(5-6):527-37. PubMed ID: 17069884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]